Zhuo, Changhua
Ruan, Qiang
Zhao, Xiangqian
Shen, Yangkun
Lin, Ruirong
Funding for this research was provided by:
the Joint for the innovation of Science and Technology of Fujian Province (2018Y9106)
the Natural Science Funds of Fujian Province (2019J01198)
Medical Innovation Project of Fujian Province (2022CXA060)
Article History
Received: 31 August 2022
Accepted: 17 November 2022
First Online: 25 November 2022
Declarations
:
: The research protocol was approved by the institutional review board the Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, China (Approval Nos. SQ2019-034-01 and SQ2022-237). For analyses of de-identifed data from TCGA and GEO databases, informed consent and human ethics review committee of approval were not required. Animal procedures were approved by the Animal Care and Use Committee of Fujian Medical University (Approval No. SYXK(Min)2016-0006 and SYXK(Min)2022-0003).
: All authors reviewed the manuscript and approved for the publication.
: The authors have no conflicts of interest to declare.